Treatment and Outcomes of Precocious Puberty: An Update
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Precocious puberty is a common problem affecting up to 29 per 100,000 girls per year. The earliest identified neuroendocrine change in early puberty thus far is increased kisspeptin secretion from the arcuate nucleus and the anteroventral paraventricular nucleus of the hypothalamus. The regulation of kisspeptin secretion is not well understood, but neurokinin B and dynorphin provide autocrine regulation. The etiologies of precocious puberty may be subdivided into GnRH-dependent and GnRH-independent causes. GnRH-dependent precocious puberty, often called central precocious puberty (CPP), is usually treated with GnRH analogs. Newer developments in the treatment of CPP include expanded data on the safety and efficacy of the subdermal histrelin implant, which is useful for long-term treatment, although removal may be difficult in some cases. Preliminary data suggest that the implant may be left in place for up to 2 years without loss of biochemical suppression. In the last 2 years, more data have been published concerning extended-release leuprolide acetate injections that indicate that the 11.25-mg dose may not provide full biochemical suppression but may clinically suppress signs of puberty, including the accelerated growth velocity and advanced skeletal maturation seen in CPP. Treatment options for familial male-limited precocious puberty and McCune-Albright syndrome are expanding as well, although data are preliminary. Long-term outcome studies of CPP indicate overall good menstrual and reproductive function, but the prevalence of polycystic ovary syndrome may be higher than in the general population. Remarkably few studies have evaluated the behavioral and psychological outcomes of precocious puberty, in contrast to early normal maturation. Additional outcome studies of endocrine, metabolic, and psychological effects of CPP are clearly needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Enlarged testis corresponding with the pubertal stage suggests GDPP, while pre-pubertal testis indicates GIPP.”
From Congenital adrenal hyperplasia complicated by gonadotropin-dependent precocious puberty (2024) · cites this paper as [16]
In the citing paper
“Pubertal testis smaller than expected with pubic hair growth means apparent LH excess (hCG-secreting tumour or testotoxicosis) or GDPP superimposed on GIPP.16”
From Congenital adrenal hyperplasia complicated by gonadotropin-dependent precocious puberty (2024) · cites this paper as [16]
In the citing paper
“The most important pointer to the source of androgen production in a boy with precocious puberty is testicular volume.”
From Congenital adrenal hyperplasia complicated by gonadotropin-dependent precocious puberty (2024) · cites this paper as [16]
Citations
Cites
Variations in pattern of pubertal changes in girls
Marshall, W. A., & Tanner, J. M. (1969) · Archives of Disease in Childhood · doi:10.1136/adc.44.235.291 · Cited by 5,963 · cited 1×
“The degree of pubertal maturation is usually described using the Tanner stages of sexual maturation (4) (Table 1).”
MethodHerman-Giddens, M. E., Slora, E. J., Wasserman, R. C., Bourdony, C. J., Bhapkar, M. V., Koch, G. G., & Hasemeier, C. M. (1997) · PEDIATRICS · doi:10.1542/peds.99.4.505 · Cited by 1,709
Topaloglu, A. K., Reimann, F., Guclu, M., Yalin, A. S., Kotan, L. D., Porter, K. M., Serin, A., Mungan, N. O., Cook, J. R., Ozbek, M. N., et al. (2009) · Nature Genetics · doi:10.1038/ng.306 · Cited by 961 · cited 1×
“Although mutations of neurokinin b and dynorphin could theoretically cause early pubertal development, such mutations have not yet been identified (12).”
BackgroundConsensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children
Carel, J.-C., Eugster, E. A., Rogol, A., Ghizzoni, L., Palmert, M. R., & on behalf of the members of the ESPE-LWPES GnRH Analogs Consensus Conference Group (2009) · Pediatrics · doi:10.1542/peds.2008-1783 · Cited by 817 · cited 2×
“in those with CPP (30) than in those with normal puberty,”
BackgroundEarlier Onset of Puberty in Girls: Relation to Increased Body Mass Index and Race
Kaplowitz, P. B., Slora, E. J., Wasserman, R. C., Pedlow, S. E., & Herman-Giddens, M. E. (2001) · Pediatrics · doi:10.1542/peds.108.2.347 · Cited by 751
Wakabayashi, Y., Nakada, T., Murata, K., Ohkura, S., Mogi, K., Navarro, V. M., Clifton, D. K., Mori, Y., Tsukamura, H., Maeda, K.-I., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5848-09.2010 · Cited by 597 · cited 5×
“org J Clin Endocrinol Metab, June 2013, 98(6):2198–2207 doi: 10.”
BackgroundInfluentialA GPR54 -Activating Mutation in a Patient with Central Precocious Puberty
Teles, M. G., Bianco, S. D. C., Brito, V. N., Trarbach, E. B., Kuohung, W., Xu, S., Seminara, S. B., Mendonca, B. B., Kaiser, U. B., & Latronico, A. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073443 · Cited by 572 · cited 1×
“in individuals with precocious puberty (10, 11).”
Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index
Rosenfield, R. L., Lipton, R. B., & Drum, M. L. (2009) · PEDIATRICS · doi:10.1542/peds.2008-0146 · Cited by 499
Herman-Giddens, M. E., Steffes, J., Harris, D., Slora, E., Hussey, M., Dowshen, S. A., Wasserman, R., Serwint, J. R., Smitherman, L., & Reiter, E. O. (2012) · PEDIATRICS · doi:10.1542/peds.2011-3291 · Cited by 392
Sørensen, K., Mouritsen, A., Aksglaede, L., Hagen, C. P., Mogensen, S. S., & Juul, A. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336325 · Cited by 386
Donato, J., Cravo, R. M., Frazão, R., Gautron, L., Scott, M. M., Lachey, J., Castro, I. A., Margatho, L. O., Lee, S., Lee, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45106 · Cited by 360 · cited 1×
“whether leptin acts via an intermediate cell (8).”
BackgroundMutations of the KISS1 gene in disorders of puberty
Silveira, L. G., Noel, S. D., Silveira-Neto, A. P., Abreu, A. P., Brito, V. N., Santos, M. G., Bianco, S. D. C., Kuohung, W., Xu, S., Gryngarten, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2421 · Cited by 352 · cited 1×
“in individuals with precocious puberty (10, 11).”
Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls
Biro, F. M., Galvez, M. P., Greenspan, L. C., Succop, P. A., Vangeepuram, N., Pinney, S. M., Teitelbaum, S., Windham, G. C., Kushi, L. H., & Wolff, M. S. (2010) · Pediatrics · doi:10.1542/peds.2009-3079 · Cited by 348
Mayer, C., Acosta-Martinez, M., Dubois, S. L., Wolfe, A., Radovick, S., Boehm, U., & Levine, J. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012406108 · Cited by 341 · cited 1×
“(7), and decreases in the intensity of this negative feedback”
BackgroundIdentifying Children at Risk for Polycystic Ovary Syndrome
Rosenfield, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2012 · Cited by 288 · cited 1×
“well above that expected for healthy young women (54).”
BackgroundThe timing of puberty: is it changing? Does it matter?
Walvoord, E. C. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2010.05.018 · Cited by 277 · cited 1×
“This has been extensively reviewed elsewhere (15).”
Outcomes of early pubertal timing in young women: a prospective population-based study
Copeland, W., Shanahan, L., Miller, S., Costello, E. J., Angold, A., & Maughan, B. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09081190 · Cited by 271 · cited 1×
“There is a wealth of data regarding long-term behavioral and emotional outcomes of girls with puberty occurring in the normal time frame but earlier than average, and these generally point to more frequent risk-taking and delinquent behaviors, earlier sexual debut, and more sex partners (56, 57).”
BackgroundMcCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia
Collins, M. T., Singer, F. R., & Eugster, E. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-s1-s4 · Cited by 256 · cited 1×
“Attempts at treatment have focused on aromatase inhibition or partial estrogen receptor blockade (45).”
BackgroundGonadotropin Secretory Dynamics During Puberty in Normal Girls and Boys
OERTER, K. E., URIARTE, M. M., ROSE, S. R., BARNES, K. M., & CUTLER, G. B. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-5-1251 · Cited by 251
Increased Risk of Precocious Puberty in Internationally Adopted Children in Denmark
Teilmann, G., Pedersen, C. B., Skakkebæk, N. E., & Jensen, T. K. (2006) · Pediatrics · doi:10.1542/peds.2005-2939 · Cited by 245
Teilmann, G., Pedersen, C. B., Jensen, T. K., Skakkebæk, N. E., & Juul, A. (2005) · Pediatrics · doi:10.1542/peds.2005-0012 · Cited by 241 · cited 1×
“The incidence in boys was approximately 10- to 15-fold lower (1).”
BackgroundInfluence of obesity on timing of puberty
BIRO, F. M., KHOURY, P., & MORRISON, J. A. (2006) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00602.x · Cited by 241
Apter, D. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.4.940 · Cited by 208
Susman, E. J., Houts, R. M., Steinberg, L., Belsky, J., Cauffman, E., DeHart, G., Friedman, S. L., Roisman, G. I., Halpern-Felsher, B. L., & for the Eunice Kennedy Shriver NICHD Early Child Care Research Network (2010) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.261 · Cited by 197
Soriano-Guillén, L., Corripio, R., Labarta, J. I., Cañete, R., Castro-Feijóo, L., Espino, R., & Argente, J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1025 · Cited by 179 · cited 1×
“it is hypothesized that nutritional deprivation in early life followed by increased adiposity after adoption triggers the endocrine and physical changes of puberty earlier than would have otherwise occurred (2, 23).”
BackgroundStockman, J. A. (2007) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)70076-9 · Cited by 172
Magiakou, M. A., Manousaki, D., Papadaki, M., Hadjidakis, D., Levidou, G., Vakaki, M., Papaefstathiou, A., Lalioti, N., Kanaka-Gantenbein, C., Piaditis, G., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0793 · Cited by 160 · cited 1×
“In another study, 21% of subjects evaluated between ages 16 and 32 had PCOS by the National Institutes of Health criteria, but there was a relatively low recruitment rate, potentially biasing the results (50).”
BackgroundKisspeptins in Reproductive Biology: Consensus Knowledge and Recent Developments1
Roa, J., Navarro, V. M., & Tena-Sempere, M. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.091538 · Cited by 143
Eugster, E. A., Clarke, W. L., Kletter, G. B., Lee, P. A., Neely, E. K., Reiter, E. O., Saenger, P. H., Shulman, D. I., Silverman, L. A., Flood, L., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2479 · Cited by 121 · cited 1×
“The first report of a large-scale treatment study in 2007 included data on 36 subjects (33 girls) and found that stimulated LH concentrations declined quickly and suppression was maintained for 1 year (31).”
BackgroundJung, H., Carmel, P. W., Schwartz, M. S., Witkin, J. W., Bentele, K. H. P., Westphal, M., Piatt, J. H., da Costa, M. E. L. T., Cornea, A. M., Ma, Y. J., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6185 · Cited by 117 · cited 1×
“Although this form of precocious puberty has been attributed to an ectopic source of GnRH pulsatility within the hamartoma, there is evidence that neuroglial effects on hypothalamic GnRH neurons may play a role (14).”
BackgroundLetrozole Treatment of Precocious Puberty in Girls with the McCune-Albright Syndrome: A Pilot Study
Feuillan, P., Calis, K. A., Hill, S. C., Shawker, T. H., Robey, P. G., & Collins, M. T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2350 · Cited by 115
Xhrouet‐Heinrichs, D., Lagrou, K., Heinrichs, C., Craen, M., Dooms, L., Malvaux, P., Kanen, F., & Bourguignon, J. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb08602.x · Cited by 108 · cited 1×
“The only 2 studies examining the effect of GnRHa on psychological outcomes of girls with CPP showed no consistent abnormalities at baseline and variable treatment effects among subjects (58, 59), but these were both published more than 10 years ago.”
BackgroundCarel, J.-C., Lahlou, N., Jaramillo, O., Montauban, V., Teinturier, C., Colle, M., Lucas, C., T. F. L. T. G., & Chaussain, J. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-020243 · Cited by 108
Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism
Ibáñez, L., Díaz, R., López-Bermejo, A., & Marcos, M. V. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9096-y · Cited by 106
Lahlou, N., Roger, M., Chaussain, J., Feinstein, M.-C., Sultan, C., Toublanc, J. E., Schally, A. V., & Scholler, R. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-5-946 · Cited by 97 · cited 1×
“Unlike intact gonadotropins, free -subunit levels paradoxically increase with GnRHa pubertal suppression (34).”
BackgroundVery Long-Term Follow-Up of Girls with Early and Late Menarche
Johansson, T., & Ritz�n, E. M. (2005) · Endocrine Development · doi:10.1159/000084098 · Cited by 91 · cited 1×
“There is a wealth of data regarding long-term behavioral and emotional outcomes of girls with puberty occurring in the normal time frame but earlier than average, and these generally point to more frequent risk-taking and delinquent behaviors, earlier sexual debut, and more sex partners (56, 57).”
BackgroundBadaru, A., Wilson, D. M., Bachrach, L. K., Fechner, P. Y., Gandrud, L. M., Durham, E., Wintergerst, K. A., Chi, C., Klein, K. O., & Neely, E. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1500 · Cited by 90
Leschek, E. W. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.175 · Cited by 87
Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty
Franceschi, R., Gaudino, R., Marcolongo, A., Gallo, M. C., Rossi, L., Antoniazzi, F., & Tatò, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.11.016 · Cited by 76 · cited 4×
“First Published Online March 20, 2013 Abbreviations: ARC, arcuate nucleus; BMI, body mass index; CNS, central nervous system; CPP, central precocious puberty; FMPP, familial male-limited precocious puberty; GnRHa, GnRH analog(s); KNDy, Kisspeptin, Neurokinin B, Dynorphin; MAS, McCune-Albright syndrome; PA, premature a…”
BackgroundInfluentialLee, P. A., Klein, K. O., Mauras, N., Neely, E. K., Bloch, C., Larsen, L. M., Mattia‐Goldberg, C., & Chwalisż, K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2704 · Cited by 72
Contribution of glial–neuronal interactions to the neuroendocrine control of female puberty
Ojeda, S. R., Lomniczi, A., & Sandau, U. S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07515.x · Cited by 71
Poomthavorn, P., Suphasit, R., & Mahachoklertwattana, P. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.507289 · Cited by 68
Psychological assessments before and after treatment of early puberty in adopted children
Mul, D., BIEMAN, H. J. M. V.-D., Slijper, F., Oostdijk, W., Waelkens, J., & Drop, S. (2001) · Acta Paediatrica · doi:10.1080/080352501316978011 · Cited by 64
Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
Neely, E. K., Lee, P., Bloch, C., Larsen, L. M., Yang, D., Mattia‐Goldberg, C., & Chwalisż, K. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-398639 · Cited by 60
Fuld, K., Chi, C., & Neely, E. K. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.05.036 · Cited by 59
Bicalutamide and Third-Generation Aromatase Inhibitors in Testotoxicosis
Lenz, A. M., Shulman, D., Eugster, E. A., Rahhal, S., Fuqua, J. S., Pescovitz, O. H., & Lewis, K. A. (2010) · Pediatrics · doi:10.1542/peds.2010-0596 · Cited by 55 · cited 1×
“5 and 5 years indicated continued suppression of androgenic findings, slower bone age progression, and increased predicted adult height (44).”
BackgroundSelf-citationReiter, E. O., Mauras, N., McCormick, K., Kulshreshtha, B., Amrhein, J., De Luca, F., O'Brien, S., Armstrong, J., & Melezinkova, H. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.161 · Cited by 54 · cited 1×
“The BATT study (Bicalutamide and Anastrozole Treatment of Testotoxicosis), a multicenter, 1-year, industry-sponsored study of 14 boys with FMPP using the newer androgen receptor antagonist bicalutamide along with the third-generation aromatase inhibitor anastrozole, found that these agents were effective in slowing gr…”
BackgroundLeuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
Neely, E. K., Lee, P. A., Bloch, C., Larsen, L. M., Yang, D., Mattia‐Goldberg, C., & Chwalisż, K. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/398639 · Cited by 53 · cited 2×
“In an industry-sponsored clinical trial, Neely et al (52) recontacted 20 female subjects out of a cohort of 49 girls treated for CPP for an average of 3.5 years.”
BackgroundInfluentialSathasivam, A., Rosenberg, H. K., Shapiro, S., Wang, H., & Rapaport, R. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.02.032 · Cited by 52 · cited 1×
“In girls, pelvic ultrasonography to assess ovarian volume is not sufficiently sensitive to distinguish the form of precocious puberty (28), but it may be helpful as an adjunct to other studies.”
ResultLee, P. A., Neely, E. K., Fuqua, J. S., Yang, D., Larsen, L. M., Mattia‐Goldberg, C., & Chwalisż, K. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-7 · Cited by 51
Self-citationMiller, B. S., & Shukla, A. R. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.09.009 · Cited by 37 · cited 1×
“reported during the use of the histrelin implant (36).”
BackgroundFulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome
Sims, E. K., Garnett, S., Guzman, F., Paris, F., Sultan, C., & Eugster, E. A. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-26 · Cited by 35 · cited 1×
“A recently published clinical trial of fulvestrant, a pure estrogen receptor blocker, showed promising results (47).”
BackgroundVerónica Mericq, G., Lammoglia, J. J., Unanue, N., Villarroel, C., Hernández, M. I., Ávila, A., Íñiguez, G., & Klein, K. O. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03584.x · Cited by 33 · cited 3×
“Percentage of Subjects Demonstrating Biochemical Suppression While Receiving Extended-Release Leuprolide Acetate Mericq et al. (41), n 14 Fuld et al. (39), n 54 Lee et al. (40), n 84 n in group Percent biochemical suppression (peak LH < 4 U/L) n in group Percent biochemical suppression (peak LH < 4 U/L) n in group Per…”
ResultInfluentialTaşçılar, M. E., Bilir, P., Akıncı, A., Köse, K., Akçora, D., Inceoğlu, D., & Fitöz, S. (2011) · PubMed · Cited by 32
Rahhal, S. N., Clarke, W., Kletter, G. B., Lee, P., Neely, E. K., Reiter, E. O., Saenger, P. H., Shulman, D. I., Silverman, L. A., & Eugster, E. (2009) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2009-812517 · Cited by 31
Rahhal, S. N., Clarke, W. L., Kletter, G. B., Lee, P. A., Neely, E. K., Reiter, E. O., Saenger, P. H., Shulman, D. I., Silverman, L. A., & Eugster, E. A. (2009) · International Journal of Pediatric Endocrinology · doi:10.1155/2009/812517 · Cited by 28 · cited 1×
“A subset of 31 subjects went on to have a second implant inserted after 1 year, and these subjects were followed for an additional year (32).”
BackgroundJaruratanasirikul, S., & Thaiwong, M. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.006 · Cited by 23
Kaplowitz, P. B. (2011) · Advances in Pediatrics · doi:10.1016/j.yapd.2011.03.004 · Cited by 23 · cited 1×
“Findings that suggest pathology include a rapid tempo of progression; advanced development; rapid linear growth; advanced skeletal maturation; and in girls, the presence of both breasts and pubic hair (27).”
BackgroundGonadotropin Pulsatile Secretion in Girls with Premature Menarche
Saggese, G., Ghirri, P., Vecchio, A. D., Papini, A., & Pardi, D. (2008) · Hormone Research · doi:10.1159/000181436 · Cited by 21
Hirsch, H. J., Lahlou, N., Gillis, D., Strich, D., Rosenberg-Hagen, B., Chertin, B., Farkas, A., Hartman, H., & Spitz, I. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2078 · Cited by 15
Prediction Models for Insulin Resistance in Girls with Premature Adrenarche
Vuguin, P. M., Grinstein, G., Freeman, K. D., Saenger, P. H., & DiMartino-Nardi, J. (2006) · Hormone Research in Paediatrics · doi:10.1159/000092103 · Cited by 11
Cited by
Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium
Bangalore Krishna, K., Fuqua, J. S., Rogol, A. D., Klein, K. O., Popovic, J., Houk, C. P., Charmandari, E., & Lee, P. A. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501336 · Cited by 293
Self-citationGnRH and GnRH receptors in the pathophysiology of the human female reproductive system
Maggi, R., Cariboni, A. M., Marelli, M. M., Moretti, R. M., Andrè, V., Marzagalli, M., & Limonta, P. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv059 · Cited by 269
“Recently it has also been proposed that neurokinin B and leptin may play an essential role in the activation of GnRH neurons and in the initiation of an increased LH pulse frequency under a PCOSlike androgen excess and that kisspeptin may coordinate their stimulatory effects on LH release (Yan et al., 2014).”
BackgroundInfluentialAdolescent Growth and Development
Chulani, V. L., & Gordon, L. P. (2014) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2014.05.002 · Cited by 186
Diagnosis and management of precocious sexual maturation: an updated review
Cheuiche, A. V., da Silveira, L. G., de Paula, L. C. P., Lucena, I. R. S., & Silveiro, S. P. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-04022-1 · Cited by 183
Mental Health Concerns and Insurance Denials Among Transgender Adolescents
Nahata, L., Quinn, G. P., Caltabellotta, N. M., & Tishelman, A. C. (2017) · LGBT Health · doi:10.1089/lgbt.2016.0151 · Cited by 158
“Despite scant research documenting positive or negative psychosocial outcomes among youth with precocious puberty, they are still routinely granted insurance coverage for puberty blockers due to potential psychosocial concerns, whereas transgender youth are not.(26,34) With significantly more data documenting the psyc…”
Metadata
- Authors
- Fuqua, J. S.
- Affiliations
- Indiana University Indianapolis (US)
- Corresponding author
- Fuqua, John S.
- ORCID
- Fuqua, John S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-06-01
- Volume
- 98
- Issue
- 6
- Pages
- 2198-2207
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2170468182
- Cited by
- 260
- References
- 61
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 20 · 2023: 27 · 2022: 17 · 2021: 23 · 2020: 21 · 2019: 23 · 2018: 12 · 2017: 22 · 2016: 13 · 2015: 31 · 2014: 20 · 2013: 4
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- precocious puberty, central precocious puberty, GnRH analogues, kisspeptin, neurokinin B, dynorphin, leuprolide, familial male-limited precocious puberty, McCune-Albright syndrome, polycystic ovary syndrome, skeletal maturation, psychological outcomes, treatment outcomes
- MeSH terms
- Delayed-Action Preparations, Drug Implants, Female, Humans, Gonadotropin-Releasing Hormone, Male, Puberty, Puberty, Precocious, Leuprolide, Treatment Outcome, Kisspeptins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.